Predicting Who Benefits From Robotic Walking Training in Neurological Disease
Studies which adults with neurological conditions respond to robotic gait training.
Key facts
- Who runs it
- Fondazione Don Carlo Gnocchi ETS
- Where
- Milan, ItalySee the site
- Trial code
- Registry title
- Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System
- Status
- Recruiting
- People taking part
- 260 people, planned
- Started
- 13 May 2022
- Expected to end
- 1 Apr 2027
- Type of study
- Observational
- Treatments tested
- Robotic Assisted Gait Training with G-EO system
- Record updated
- 9 August 2022
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with multiple sclerosis, Parkinson disease, stroke or acquired brain injury who will have robotic walking training with the G-EO system.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Diagnosis of multiple sclerosis, Parkinson disease, stroke or acquired brain injury. Must be able to walk at least 10 meters, also with aid.
- Earlier treatment
- Robotic treatment with the G-EO system must be in the therapeutic plan. At least 10 sessions, at least 2 per week.
Main reasons for not taking part
- Severe limits in joint range of motion
- Medical problems that make walking hard, such as fractures, pain, severe osteoporosis or severe spasticity
- Skin lesions where the device touches the body
- Seizures that may be triggered by the G-EO system
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Diagnosis of Multiple Sclerosis, Parkinson Disease, Stroke or acquired brain injury
- Minimum number of sessions: 10 sessions with the GEO system
- Minimum frequency of sessions: 2 per week
- Age ≥ 18 years
- Ability to walk for at least 10 meters, also with aid
- Indication of robotic treatment in the therapeutic plan
- Body size suitable for the robotic device
- ability to maintain verticality for 7 minutes
- ability to maintain the sitting position without support for 30 seconds
Who cannot take part
- Presence of seizures that may be triggered by the use of the G-EO system
- severe limitations of articular range of motion
- medical problems compromising walking (e.g. fractures, pain, severe osteoporosis or severe spasticity)
- Presence of skin lesions in the areas of contact with the device
Where in Italy
- Don Gnocchi FoundationMilan, ItalyContact: Davide Cattaneo, PhDTaking people
About the trial
What the trial wants to find out
The aim of this work is to elaborate a statistical model to predict the effectiveness of robotic treatment in subjects with neurological diseases. The model will be used to understand which subjects are most responsive to this type of treatment
The group in the trial
- People with neurological disease according to inclusion criteria
People with neurological disease (Multiple Sclerosis, Parkinson Disease, Stroke and acquired brain injuries) will be recruited according to inclusion and exclusion criteria.
Treatment: Robotic Assisted Gait Training with G-EO system
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System: an Observational Longitudinal Study
- Plain-language title
- Predicting Who Benefits From Robotic Walking Training in Neurological DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 August 2022